Vous êtes ici : Accueil > Labo BCI > Publications du laboratoire en 2017

Publications du laboratoire en 2017

Publié le 8 mars 2017



Bestgen B, Belaid-Choucair Z, Lomberget T, Le Borgne M, Filhol O and Cochet C
In search of small molecule inhibitors targeting the flexible CK2 subunit interface.
Pharmaceuticals (Basel), 2017, 10(1): Article number 16

Burute M, Prioux M, Blin G, Truchet S, Letort G, Tseng Q, Bessy T, Lowell S, Young J, Filhol O and Thery M
Polarity reversal by centrosome repositioning primes cell scattering during epithelial-to-mesenchymal transition.
Developmental Cell, 2017, 40(2): 168-184

Desroches-Castan A, Feige JJ and Cherradi N
ACTH action on messenger RNA stability mechanisms.
Frontiers in Endocrinology, 2017, 8: 3

Guignabert C, Bailly S and Humbert M
Restoring BMPRII functions in pulmonary arterial hypertension: Opportunities, challenges and limitations.
Expert Opinion on Therapeutic Targets, 2017, 21(2): 181-190

Rochefort P, Chabaud S, Pierga JY, Tredan O, Brain E, Bidard FC, Schiffler C, Polena H, Khalil-Mgharbel A, Vilgrain I and Bachelot T
Soluble VE-cadherin in metastatic breast cancer: An independent prognostic factor for both progression-free survival and overall survival.
British Journal of Cancer, 2017, 116(3): 356-361